BACKGROUND: Vaccine development targeting the novel immunogenic Per ARNT Sim Domain containing 1 (PASD1) cancer testis antigen represents an attractive therapeutic approach for the significant number of patients with diffuse large B-cell lymphoma who are refractory to conventional treatment. Since CD4-positive T helper cells have crucial roles in promoting and maintaining immune responses to tumor antigens, the presence of a CD4-positive T-helper immune response to the PASD1 antigen in patie...Expand abstract
- Publisher copy:
- Copyright date:
CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.
If you are the owner of this record, you can report an update to it here: Report update to this record